Inventor · disambiguated record
Ronald A. Pruzan
Also filed as: PRUZAN RONALD · PRUZAN RONALD A
15 granted patents·2 pending applications·259 citations·filing 1996–2022
93Inventor score
Top patents by PatentIndex Score
17 records- 0195US6517834B1Purified telomeraseGERON CORP·Filed 2000·Granted Feb 11, 2003·48 cites·20 claims
- 0292US6787133B2Using purified telomerase to identify telomerase activators and inhibitorsGERON CORP·Filed 2002·Granted Sep 7, 2004·31 cites·25 claims
- 0389US6261556B1Purified telomeroseGERON CORP·Filed 1999·Granted Jul 17, 2001·81 cites·12 claims
- 0488US6545133B1Methods for purifying telomeraseGERON CORP·Filed 2000·Granted Apr 8, 2003·19 cites·22 claims
- 0584US11279720B2Guanine analogs as telomerase substrates and telomere length affectorsGERON CORP·Filed 2020·Granted Mar 22, 2022·1 cites·32 claims
- 0681US9228189B2C-myc antisense oligonucleotides and methods for using the same to treat cell-proliferative disordersGERON CORP·Filed 2013·Granted Jan 5, 2016·3 cites·39 claims
- 0781US7067283B2Producing telomerase activators and inhibitors by screening with purified telomeraseGERON CORP·Filed 2004·Granted Jun 27, 2006·7 cites·25 claims
- 0879US12398162B2Guanine analogs as telomerase substrates and telomere length affectorsGERON CORP·Filed 2022·Granted Aug 26, 2025·0 cites·34 claims
- 0977US5846723AMethods for detecting the RNA component of telomeraseGERON CORP·Filed 1996·Granted Dec 8, 1998·43 cites·38 claims
- 1068US5968506APurified telomeraseGERON CORP·Filed 1997·Granted Oct 19, 1999·26 cites·7 claims
- 1166US10562926B2Guanine analogs as telomerase substrates and telomere length affectorsGERON CORP·Filed 2018·Granted Feb 18, 2020·0 cites·30 claims
- 1266US2006166254A1Protocol for optimizing purification of enzymatically active human telomeraseWEINRICH SCOTT L·Filed 2006·Application pending·0 cites
- 1362US10035814B2Guanine analogs as telomerase substrates and telomere length affectorsGERON CORP·Filed 2017·Granted Jul 31, 2018·0 cites·34 claims
- 1461US9593137B2Guanine analogs as telomerase substrates and telomere length affectorsGERON CORP·Filed 2012·Granted Mar 14, 2017·0 cites·63 claims
- 1553US9771581B2C-myc antisense oligonucleotides and methods for using the same to treat cell-proliferative disordersGERON CORP·Filed 2015·Granted Sep 26, 2017·0 cites·36 claims
- 1639US2008213812A1Methods and compositions for modulating telomerase reverse transcriptase (TERT) expressionANDREWS WILLIAM H·Filed 2008·Application pending·0 cites
- 1730US7585966B1Inhibitory polynucleotides directed against the RNA component of telomeraseGERON CORP·Filed 1999·Granted Sep 8, 2009·0 cites·9 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →